Organic chemistry News and Research

RSS

TPU scientists developing bioactive coating for medical implants

A group of young scientists from Tomsk Polytechnic University are developing a bioactive coating for medical implants. Due to its properties, it will be able to "convince" the body not to reject the artificial bones and joints.

2 Nov 2016

Compound bearing hidden chirality can trigger autocatalytic preparation of chiral organic intermediates

The preparation of chiral compounds as intermediates in drug synthesis is one of the most important targets in synthetic organic chemistry.

20 Oct 2016

New JGU cyclotron to be employed for research into potential applications in medicine

A new particle accelerator is further enhancing the research landscape at Johannes Gutenberg University Mainz.

14 Sep 2016

Chemists find efficient way to convert organic molecules into new medicines

Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.

2 Sep 2016

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry.

17 Aug 2016

Scientists discover way to visualize function of bone-resorbing cells in living mice

Researchers of Osaka University have discovered a way to visualize sites where bone-resorbing cells (osteoclasts) were in the process of resorbing bone in living mice.

17 Aug 2016

Researchers succeed in activating a 'single-molecule switch'

Everybody knows the force that is required to activate a light switch on a wall - a finger is enough. But how much force do you need to apply if the device was dramatically reduced to the "nanoscale world", that is, how much force do you need to operate a "single-molecule switch"? This fundamental question is related not only to basic science but also to potential future applications of molecular devices.

18 Jul 2016

Compounds extracted from parsley and dill seeds may help fight cancer

A team of Russian scientists from Moscow Institute of Physics and Technology, the N. D. Zelinsky Institute of Organic Chemistry, the Institute of Developmental Biology, and the Institute of Cell Biophysics proposed an efficient approach to a novel agents with anticancer activity.

29 Jun 2016

Pittcon 2015: Bruker introduces InsightMR software for on-line NMR analysis of chemical processes

Bruker is launching InsightMR software for on-line NMR analysis of chemical processes at Pittcon 2015. For the first time, a software platform enables the adjustment of experimental parameters based on real time data during the analysis of chemical processes by NMR spectroscopy.

From Bruker BioSpin - NMR, EPR and Imaging 15 Mar 2016

Researchers uncover antitumoral nature of maslinic acid in colon cancer cells

Researchers from the University of Granada, in collaboration with the universities of Barcelona and Jaen, have brought to light the antitumoral nature of maslinic acid (a compound derived from olives) in Caco-2 p53-deficient colon adenocarcinoma cells in the short term.

11 Mar 2016

Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Björn Wängler

Interview conducted with Professor Björn Wängler, Professor for Molecular Imaging and Radiochemistry from Heidelberg University.

From Bruker BioSpin - NMR, EPR and Imaging 4 Feb 2016

JGU employs new particle accelerator to enhance research into radiopharmaceutical chemistry

A new particle accelerator will further enhance the research landscape at Johannes Gutenberg University Mainz. It is to be employed to conduct research into potential applications of medical relevance.

5 Jan 2016

UCA researchers identify compounds that favour generation of new neuronal cells

Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.

17 Dec 2015

WuXi PharmaTech announces winners of Life Science and Chemistry Awards

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced the winners of the ninth annual WuXi PharmaTech Life Science and Chemistry Awards at a ceremony held on December 13 at Diaoyutai State Guesthouse in Beijing.

14 Dec 2015

New chemical method developed to introduce alkenes into simple hydrocarbon molecules

Chemists at Princeton have developed a new chemical method to introduce valuable alkenes into simple hydrocarbon molecules, a transformation known as dehydrogenation, which is found in important processes such as the biosynthesis of essential fatty acids in the body and the commercial production of detergents.

13 Dec 2015

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

22 Nov 2015

Unlocking the genes behind antibiotic resistance: an interview with Professor Romesberg

Bacteria are very, very diverse. This is why their susceptibility to different antibiotics can be very different. It also makes the tools they have to evolve resistance in many cases different.

30 Sep 2015

New technique could improve selectivity of cancer drugs, decrease unwanted side effects in future

A class of therapeutic drugs known as protein kinase inhibitors has in the past decade become a powerful weapon in the fight against various life-threatening diseases, including certain types of leukemia, lung cancer, kidney cancer and squamous cell cancer of the head and neck.

11 Sep 2015

Johns Hopkins, IOCB Prague sign drug discovery research agreement

The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.

9 Jul 2015

Hartmuth Kolb named recipient of 2015 Alzheimer Award

The Journal of Alzheimer's Disease is proud to announce that Hartmuth Kolb, PhD, Head of Neuroscience Biomarkers, Johnson & Johnson, San Diego, CA, has been chosen as the recipient of the 2015 Alzheimer Award presented by the Journal of Alzheimer's Disease in recognition of his outstanding work on the importance and imaging of neurofibrillary tangles (NFTs) and Alzheimer's disease (AD).

26 Jun 2015